Ueland T, Dahl TB, Michelsen A, Kleveland O, Andersen GØ, Anstensrud AK, Huse C, Woxholt S, Broch K, Gullestad L, Libby P, Aukrust P, Halvorsen B (2026)
Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial
Arterioscler Thromb Vasc Biol (in press)
DOI 10.1161/ATVBAHA.125.323587, PubMed 42021733

Myhre AE, Meyer-Myklestad MH, Gullaksen HH, Søgaard OS, Tolstrup M, Salgado M, Martinez-Picado J, Holberg-Petersen M, Juhl AK, Schleimann MH, Gunst JD, Thomsen A, Fisher K, Bhamra JS, Kran AB, Halvorsen B, Dyrhol-Riise AM, Reikvam DH, Aukrust P, Gedde-Dahl T, Oslo HIV Cure Study Group, Dahl TB, Kaarbø M, Trøseid M (2026)
Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor
Nat Microbiol (in press)
DOI 10.1038/s41564-026-02304-8, PubMed 41975092

Høgestøl EA, Brustad ÅW, Celius EG, Meling M, Berg-Hansen P, Kro GB, König M, Schanke Y, Halvorsen B, Warren DJ, Gehin JE, Bolstad N, Nygaard GO (2026)
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab
BMJ Neurol Open, 8 (1), e001477
DOI 10.1136/bmjno-2025-001477, PubMed 41877736